Your browser doesn't support javascript.
loading
High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.
Moreno, Daniel Antunes; Bonatelli, Murilo; Antoniazzi, Augusto Perazzolo; de Paula, Flávia Escremim; Leal, Leticia Ferro; Garcia, Felipe Antônio de Oliveira; de Paula, André Escremim; Teixeira, Gustavo Ramos; Santana, Iara Viana Vidigal; Saggioro, Fabiano; Neder, Luciano; Valera, Elvis Terci; Scrideli, Carlos Alberto; Stavale, João; Malheiros, Suzana Maria Fleury; Lima, Matheus; Hajj, Glaucia Noeli Maroso; Garcia-Rivello, Hernan; Christiansen, Silvia; Nunes, Susana; Gil-da-Costa, Maria João; Pinheiro, Jorge; Martins, Flavia Delgado; Junior, Carlos Almeida; Mançano, Bruna Minniti; Reis, Rui Manuel.
Afiliação
  • Moreno DA; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Bonatelli M; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
  • Antoniazzi AP; Cancer Genetics Department, Barretos Cancer Hospital, Barretos, Brazil.
  • de Paula FE; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
  • Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Garcia FAO; Pathology Department, Barretos Cancer Hospital, Barretos, Brazil.
  • de Paula AE; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Teixeira GR; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
  • Santana IVV; Barretos School of Health Sciences Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil.
  • Saggioro F; Pathology Department, Barretos Cancer Hospital, Barretos, Brazil.
  • Neder L; Barretos School of Health Sciences Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil.
  • Valera ET; Department of Pathology and Forensic Medicine, University of São Paulo, Ribeirão Preto, Brazil.
  • Scrideli CA; Department of Pathology and Forensic Medicine, University of São Paulo, Ribeirão Preto, Brazil.
  • Stavale J; Department of Pediatrics of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Malheiros SMF; Department of Pediatrics of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Lima M; Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • Hajj GNM; Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • Garcia-Rivello H; Oncology Department, AC Camargo Hospital, São Paulo, Brazil.
  • Christiansen S; Oncology Department, AC Camargo Hospital, São Paulo, Brazil.
  • Nunes S; Pathology Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
  • Gil-da-Costa MJ; Pathology Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
  • Pinheiro J; Pediatric Oncology Department, Centro Hospitalar Universitário São João, Porto, Portugal.
  • Martins FD; Pediatric Oncology Department, Centro Hospitalar Universitário São João, Porto, Portugal.
  • Junior CA; Department of Pathology, Centro Hospitalar Universitário São João, Porto, Portugal.
  • Mançano BM; Brasília Children's Hospital, Brasília, Brazil.
  • Reis RM; Pediatric Neurosurgery Department, Barretos Cancer Hospital, Barretos, Brazil.
Front Oncol ; 13: 1237170, 2023.
Article em En | MEDLINE | ID: mdl-37746264
Purpose: Medulloblastomas are the most common primary malignant brain tumors in children. They are divided into molecular subgroups: WNT-activated, SHH-Activated, TP53 mutant or wild type, and non-WNT/non-SHH (Groups 3 and 4). WNT-activated medulloblastomas are usually caused by mutations in the CTNNB1 gene (85%-90%), and most remaining cases of CTNNB1 wild type are thought to be caused by germline mutations in APC. So far, the frequencies of CTNNB1 have been reported mainly in North American and European populations. The aim of this study was to report the frequency of CTNNB1 mutations in WNT-activated medulloblastomas in a Latin-Iberian population and correlate with their clinicopathological characteristics. Methods: A total of 266 medulloblastomas from seven different institutions from Brazil (n=211), Portugal (n=38), and Argentina (n=17) were evaluated. Following RNA and DNA isolation from formalin-fixed, paraffin-embedded (FFPE) tumor tissues, the molecular classification and CTNNB1 mutation analysis were performed by nCounter and Sanger sequencing, respectively. Results: WNT-activated medulloblastomas accounted for 15% (40/266) of the series. We observed that 73% of WNT-activated medulloblastomas harbored CTNNB1 mutations. CTNNB1 wild-type cases (27%) were more prevalent in female individuals and suggested to be associated with a worse outcome. Among the CTNNB1 wild-type cases, the available analysis of family history revealed two cases with familiar adenomatous polyposis, harboring APC germline variants. Conclusion: We observed a lower incidence of CTNNB1 mutations in WNT-activated medulloblastomas in our Latin-Iberian cohort compared to frequencies previously described in other populations. Considering that CTNNB1 wild-type cases may exhibit APC germline mutations, our study suggests a higher incidence (~30%) of hereditary WNT-activated medulloblastomas in the Latin-Iberian population.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil